FDA removes hold on clinical trial for phase 2,3 for COVAXIN-BBV152 says Ocugen
May 23, 2022
Malvern (Pennsylvania) [US], May 23 : Biotechnology company Ocugen on Monday announced that the US Food and Drug Administration (FDA) lifted the clinical hold...